Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 14, Issue 5, Pages 1044-1055Publisher
WILEY
DOI: 10.1111/j.1582-4934.2010.01046.x
Keywords
injectable cardiac tissue engineering; stem cells; biomaterials; myocardial infarction
Categories
Funding
- National High Technology Research and Development Program of China [2006AA02A105]
- Nature Science Foundation of China [30530220]
- Beijing Nature Science Foundation of China [7062053]
Ask authors/readers for more resources
Introduction Seeding cell sources Embryonic stem cells Induced pluripotent stem cells Adult stem cells Skeletal myoblasts (SkM) Bone marrow-derived stem cells Cardiac stem cells Other adult stem cells Biomaterials in the injectable cardiac tissue engineering Fibrin Alginate Matrigel Collagen Chitosan Other biomaterials Clinical applications Future perspectives Heart disease is a leading cause of morbidity and mortality worldwide. Myocardial infarction leads to permanent loss of cardiac tissue and ultimately heart failure. However, current therapies could only stall the progression of the disease. Thus, new therapies are needed to regenerate damaged hearts to overcome poor prognosis of patients with heart failure. The shortage of heart donors is also a factor for innovating new therapies. Although the cardiac performance by cell-based therapy has improved, unsatisfactory cell retention and transplant survival still plague this technique. Because biomaterials can improve the cell retention, survival and differentiation, cardiac tissue engineering is now being explored as an approach to support cell-based therapies and enhance their efficacy for cardiac disease. In the last decade, cardiac tissue engineering has made considerable progress. Among different kinds of approaches in the cardiac tissue engineering, the approach of injectable cardiac tissue engineering is more minimally invasive than that of in vitro engineered tissue or epicardial patch implantation. It is therefore clinically appealing. In this review, we strive to describe the major progress in the flied of injectable cardiac tissue engineering, including seeding cell sources, biomaterials and novel findings in preclinical studies and clinical applications. The remaining problems will also be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available